Citicoline Sales

Citicoline Sales Market Outlook

The global Citicoline market is projected to reach approximately USD 1.2 billion by 2033, growing at a robust CAGR of around 6.5% from 2025 to 2033. This growth is attributed to the rising prevalence of neurodegenerative diseases, increasing adoption of cognitive enhancers, and an expanding aging population that increasingly seeks supplements to enhance memory and cognitive function. Moreover, advancements in healthcare and increased awareness surrounding the importance of brain health are driving demand for Citicoline products. The growing inclination towards preventive healthcare and self-medication is also contributing to the market growth as consumers seek effective solutions to support cognitive function and memory retention.

Growth Factor of the Market

The Citicoline sales market is experiencing significant growth owing to a multitude of factors that are driving consumer interest and industry investment. One of the primary growth factors is the rising awareness regarding cognitive health and the increasing prevalence of disorders such as Alzheimer's disease and other forms of dementia, which have heightened the demand for effective treatments. Furthermore, the growing trend of self-medication and preventive healthcare is prompting consumers to seek dietary supplements that can support brain health, thereby boosting the Citicoline market. The product's reputation as a nootropic, which enhances cognitive functions such as memory and focus, has attracted both consumers and healthcare professionals to advocate for its use. Additionally, innovations in product formulations and delivery methods, including more palatable options like flavored liquids and easy-to-consume tablets or capsules, have broadened the consumer base and made Citicoline more accessible. Lastly, the increasing investments in research and development by pharmaceutical companies to explore the therapeutic potentials of Citicoline in various neurological conditions are further contributing to market expansion.

Key Highlights of the Market

• The global Citicoline market is projected to witness a CAGR of 6.5% from 2025 to 2033.
• Increasing prevalence of neurodegenerative diseases fuels demand for Citicoline products.
• Growing trend of preventive healthcare and self-medication bolsters market growth.
• Innovations in product formulations have broadened the consumer base.
• Research and development investments continue to explore Citicoline's therapeutic potentials.

By Product Type

Tablets:

Tablets represent a significant segment of the Citicoline market, primarily because of their convenience and familiarity to consumers. These solid dosages are easy to store and transport, making them a popular choice among individuals seeking cognitive enhancement. The structured dosage form allows for precise consumption, which is crucial for ensuring effective intake levels. Additionally, many consumers consider tablets to be a more palatable option compared to other forms that may have distinct tastes or consistencies. The ability to manufacture tablets with controlled-release properties also adds to their appeal, as this can enhance the absorption and efficacy of Citicoline over time. As more individuals recognize the benefits of memory enhancement and cognitive support, the tablet segment is expected to witness consistent growth in market share, aligning with the broader trends of increasing health consciousness among consumers.

Capsules:

Capsules are another prominent product type in the Citicoline market, offering distinct advantages that appeal to a larger demographic. Many consumers prefer capsules because they are easier to swallow compared to tablets, making them particularly popular among older adults who may have difficulty with solid forms of medication. Moreover, capsules can be formulated to contain various ingredients in a single dose, which allows for more comprehensive cognitive support. The gelatin or plant-based materials used in capsules enable a quicker dissolution in the stomach, leading to faster absorption of Citicoline into the bloodstream. This rapid action is often preferred by consumers looking for immediate cognitive enhancements, such as improved focus or memory retention. Furthermore, the trend toward vegan and vegetarian capsules is also opening new avenues within the market, catering to the needs of health-conscious consumers focused on lifestyle choices.

Liquid:

The liquid segment of the Citicoline market is gaining traction due to the increasing popularity of liquid supplements, which are often perceived as more bioavailable than solid forms. Consumers are finding that liquid formulations can be more easily absorbed, allowing for faster effects. This is particularly important for people seeking immediate cognitive support, as it helps them achieve desired outcomes quickly. Additionally, liquids can be flavored to enhance palatability, making them attractive to younger demographics who may be more resistant to taking traditional tablets or capsules. The versatility of liquid Citicoline also allows for a variety of consumption methods, whether as a standalone supplement or mixed into smoothies and other beverages. As consumer preferences shift toward more convenient and enjoyable formats, the liquid segment is positioned for significant growth in the coming years.

By Application

Memory Enhancement:

Memory enhancement is one of the key applications driving the demand for Citicoline, as increasing numbers of consumers are seeking out cognitive enhancers to improve their memory capabilities. With growing concerns about cognitive decline associated with aging, many individuals are turning to Citicoline supplements as a proactive measure to support their brain health. Clinical studies have indicated that Citicoline may play a role in enhancing memory performance and information processing, leading to its adoption by people of various age groups. Furthermore, the rising interest in nootropics—substances that can boost cognitive function—has augmented the popularity of Citicoline as a well-researched option in this category. As awareness of the benefits of cognitive health continues to spread, the memory enhancement segment is likely to experience sustained growth in the Citicoline market.

Alzheimer’s Disease Treatment:

Citicoline is increasingly recognized for its potential in the treatment of Alzheimer’s disease, a neurodegenerative disorder characterized by progressive memory loss and cognitive decline. Research has suggested that Citicoline may help slow the progression of Alzheimer's symptoms by supporting neuronal health and promoting the synthesis of phospholipids in brain membranes. As a result, healthcare professionals are beginning to integrate Citicoline into treatment regimens for patients suffering from mild to moderate Alzheimer’s disease. The growing prevalence of this condition, combined with the lack of effective therapies, has created a significant market opportunity for Citicoline as an adjunct treatment. The supportive evidence from clinical studies reinforces the application of Citicoline in Alzheimer's management, leading to a projected increase in prescription and over-the-counter sales for this purpose.

Stroke Recovery:

The application of Citicoline in stroke recovery is gaining traction, as studies have indicated its efficacy in enhancing neurological recovery following an ischemic stroke. Citicoline is believed to play a critical role in neuroprotection and the recovery of cognitive and motor functions, which are often impaired after a stroke. This has led many healthcare providers to recommend Citicoline as part of a rehabilitation protocol for stroke patients. With the increasing incidence of strokes globally, the demand for effective recovery therapies is on the rise, thereby propelling the Citicoline market forward. The integration of Citicoline into recovery programs not only aids in physical rehabilitation but also enhances mental health and cognitive recovery, making it a valuable asset in comprehensive stroke care.

Parkinson’s Disease Treatment:

Citicoline is also being explored in the context of Parkinson’s disease treatment, a progressive neurological condition that affects movement and coordination. Research suggests that Citicoline may help improve dopamine levels in the brain, which can be beneficial for managing some symptoms associated with Parkinson’s disease. As healthcare providers look for ways to enhance the quality of life for patients suffering from this degenerative condition, Citicoline is emerging as a potential adjunct therapy. The increasing focus on holistic treatment approaches that combine medication with dietary supplements is likely to foster growth in this segment of the Citicoline market. As more data becomes available on the efficacy of Citicoline in Parkinson’s management, its adoption among both healthcare professionals and patients is expected to rise significantly.

ADHD Treatment:

The application of Citicoline in treating Attention Deficit Hyperactivity Disorder (ADHD) is garnering attention as more parents and healthcare practitioners seek safe and effective alternatives to traditional medications. Citicoline is thought to support neurotransmitter synthesis and enhance cognitive functions, which can be beneficial for children and adults with ADHD. As the stigma surrounding ADHD continues to diminish, there is an increased willingness to explore dietary and nutritional interventions, including Citicoline, as part of a comprehensive treatment plan. The rising prevalence of ADHD and the growing demand for non-stimulant treatments are expected to drive the Citicoline market in this application area. With ongoing research and positive anecdotal evidence, Citicoline's role in ADHD management is anticipated to expand, leading to greater acceptance in both pediatric and adult treatment protocols.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies play a pivotal role in the distribution of Citicoline products, particularly for patients requiring prescribed treatments for neurological disorders. These pharmacies are equipped to provide specialized formulations and dosages tailored to individual patient needs, ensuring that medications are dispensed safely and effectively. The presence of healthcare professionals who can offer guidance on the appropriate use of Citicoline complements the distribution process, enhancing patient outcomes. As hospitals aim to provide comprehensive care for conditions like Alzheimer's and stroke recovery, the demand for Citicoline from hospital pharmacies is projected to grow steadily. The supportive environment of hospital settings further strengthens the market presence of Citicoline, as clinicians increasingly recommend it as part of treatment regimens.

Retail Pharmacies:

Retail pharmacies are a crucial distribution channel for Citicoline, making these products readily available to the general public. The convenience and accessibility of retail pharmacies enable consumers to purchase Citicoline supplements over the counter without a prescription, thereby encouraging greater adoption among health-conscious individuals. As the trend toward self-medication continues to rise, many consumers are seeking cognitive enhancers like Citicoline for memory support and overall brain health. Retail pharmacies often promote these products through educational campaigns and customer engagement initiatives, which further drives consumer awareness and sales. With an increasing number of consumers taking a proactive approach to their health, the retail pharmacy segment is expected to witness significant growth in Citicoline sales.

Online Pharmacies:

Online pharmacies have emerged as a vital distribution channel for Citicoline, particularly in the wake of the digital transformation in the healthcare sector. The convenience of purchasing supplements online allows consumers to access a wider variety of products and formulations than may be available locally. Additionally, the anonymity afforded by online shopping can encourage individuals to seek cognitive enhancers like Citicoline without the stigma that may be associated with visiting a pharmacy in person. Many online pharmacies also offer detailed product information, customer reviews, and competitive pricing, which can influence purchasing decisions. As e-commerce continues to grow and more consumers embrace online shopping for healthcare products, the online pharmacy segment is poised for robust growth in the Citicoline market.

By Ingredient Type

Cytidine:

Cytidine is one of the key ingredient types in Citicoline formulations and plays an essential role in the supplement's efficacy. As a nucleoside, Cytidine is involved in the synthesis of nucleic acids, which are critical for cell function and replication. In the context of brain health, Cytidine contributes to the production of phospholipids, which are vital for maintaining cell membrane integrity and supporting neuronal function. This biochemical activity is particularly significant in conditions associated with cognitive decline and neurodegeneration, as it aids in cellular repair and regeneration. As research highlights the importance of Cytidine in promoting brain health, its presence in Citicoline products is likely to drive consumer preference, thus bolstering market growth for formulations containing this ingredient.

Choline:

Choline is another significant ingredient type found in Citicoline formulations, renowned for its essential role in numerous physiological functions, particularly in cognitive health. As a precursor for the neurotransmitter acetylcholine, Choline is crucial for memory, mood regulation, and overall brain function. Many studies have associated adequate Choline intake with improved cognitive performance and reduced risk of cognitive decline. Given the increasing awareness of dietary deficiencies impacting cognitive function, the demand for Citicoline that contains Choline is expected to grow substantially. Furthermore, as consumers seek to enhance their cognitive abilities through nutritional support, formulations rich in Choline are likely to gain favor, propelling the sales of Citicoline products in the market.

By Region

In North America, the Citicoline market is primarily driven by the rising prevalence of cognitive disorders and an increased focus on brain health among the aging population. The region is expected to dominate the market with a projected share of about 45%, exhibiting a CAGR of 7% from 2025 to 2033. The presence of well-established healthcare infrastructure and a growing trend toward preventive healthcare among consumers further bolster demand. Additionally, North America benefits from a high level of awareness regarding the benefits of cognitive enhancers, which is leading to increased adoption of Citicoline products within various therapeutic areas, including Alzheimer's treatment and memory enhancement.

In Europe, the Citicoline market is gaining momentum due to rising health consciousness and increased investment in research and development for cognitive health. The European market is estimated to account for approximately 30% of global sales and is expected to grow at a CAGR of 6% during the forecast period. There is also a significant focus on clinical research in many European countries, which is helping to validate the efficacy of Citicoline in various applications, increasing its acceptance among healthcare providers. As more healthcare professionals recommend Citicoline for memory enhancement and Alzheimer's management, this region's market is anticipated to expand significantly in the coming years.

Opportunities

The Citicoline market presents numerous opportunities as consumer awareness of cognitive health continues to grow. With the increasing prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, there is a compelling demand for effective treatments that can help mitigate symptoms and improve the quality of life for affected individuals. This creates a favorable environment for the development of new Citicoline formulations targeted at specific conditions, potentially leading to innovative delivery methods and enhanced product effectiveness. Furthermore, expanding into emerging markets where healthcare awareness is on the rise offers significant growth prospects for Citicoline manufacturers. As these markets evolve, there is an opportunity for brands to educate consumers about the benefits of Citicoline, driving demand for both prescription and over-the-counter products aimed at enhancing cognitive function.

Additionally, the growing trend of preventive healthcare is opening new avenues for Citicoline sales, particularly among younger demographics who are increasingly focused on maintaining cognitive health and performance. The integration of Citicoline into nootropic stacks and wellness products tailored for mental acuity presents a unique opportunity for market expansion. Collaborations with healthcare professionals to promote Citicoline as a part of comprehensive brain health strategies can also enhance brand credibility and capture a larger market share. As lifestyle-related cognitive concerns gain prominence, targeted marketing campaigns and educational initiatives about the cognitive benefits of Citicoline can further capitalize on this growing awareness, ensuring sustained growth in the market.

Threats

Despite the promising outlook for the Citicoline market, several threats could potentially hinder its growth trajectory. One of the main concerns is the rising competition from alternative cognitive enhancers and dietary supplements that claim similar benefits. The market is becoming increasingly saturated with products that target memory enhancement and cognitive function, leading to price wars and reduced profit margins for Citicoline manufacturers. Furthermore, the lack of standardization in supplement formulation can lead to inconsistent product quality, which might deter consumers from choosing Citicoline over other options. Regulatory challenges and the need for extensive clinical trials can also slow down the introduction of new Citicoline products, limiting market expansion opportunities. Additionally, negative press surrounding dietary supplements and potential side effects can undermine consumer trust, making it essential for manufacturers to prioritize transparency and education in their marketing efforts.

Moreover, there is a growing skepticism among consumers regarding the efficacy of supplements, including Citicoline. As more individuals become discerning about their health choices, only those products backed by robust scientific evidence and clinical research are likely to thrive. As a result, companies must invest in research and development to substantiate claims and ensure that their formulations deliver measurable results. Additionally, regulatory scrutiny regarding health claims made by supplements is increasing in various markets, making compliance crucial for successful marketing strategies. This changing landscape emphasizes the need for Citicoline manufacturers to remain agile and responsive to both market trends and consumer demands to mitigate potential risks effectively.

Competitor Outlook

• Kyowa Hakko Bio Co., Ltd.
• Hunan Dongting Pharmaceutical Co., Ltd.
• PharmaCom Bio Inc.
• Jiangsu Nanshan Pharmaceutical Co., Ltd.
• Neurohacker Collective
• Ginkgo BioWorks
• Hubei Huitian Pharmaceutical Co., Ltd.
• Thermo Fisher Scientific Inc.
• Herbalife Nutrition Ltd.
• NOW Foods
• NutraBlast
• Life Extension
• ELI LILLY AND COMPANY
• Jarrow Formulas, Inc.
• BrainMD Health
• Source Naturals, Inc.

The competitive landscape of the Citicoline market is characterized by a mix of well-established pharmaceutical companies and emerging nutraceutical brands striving to capture a share of the growing cognitive health segment. Key players are investing significantly in research and development to create innovative formulations and delivery systems that enhance the efficacy of Citicoline. As the market continues to expand, competition is intensifying, prompting companies to adopt strategies such as product differentiation, aggressive marketing campaigns, and strategic partnerships to maintain their market positions. Additionally, brands are increasingly focusing on direct-to-consumer sales through e-commerce platforms, allowing them to reach a broader audience and enhance their visibility in the marketplace.

Major companies like Kyowa Hakko Bio Co., Ltd. have been at the forefront of developing high-quality Citicoline products, emphasizing their commitment to scientific research and innovation. The company leverages its extensive experience in biotechnology to formulate effective cognitive enhancers that cater to a variety of consumer needs. Similarly, PharmaCom Bio Inc. is recognized for its focus on developing premium supplements that support brain health, with Citicoline being a key component of their product line. As competition heats up, these companies are also emphasizing the importance of sustainability and ethical sourcing in their business practices, appealing to environmentally conscious consumers who prioritize health and wellness.

Emerging players such as Neurohacker Collective are tapping into the growing interest in nootropic supplements, effectively positioning Citicoline as part of comprehensive cognitive enhancement stacks. Their marketing strategies focus heavily on consumer education and the science behind their formulations, fostering a loyal customer base that values transparency and efficacy. Meanwhile, traditional companies like Herbalife Nutrition Ltd. are broadening their product offerings to include Citicoline in response to changing consumer preferences, demonstrating a willingness to adapt to market demands. This dynamic competitive environment continues to evolve as new entrants bring fresh perspectives and innovative approaches to the Citicoline market, ultimately benefiting consumers seeking effective cognitive-enhancing solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 NOW Foods
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 NutraBlast
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 BrainMD Health
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Life Extension
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Ginkgo BioWorks
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 PharmaCom Bio Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 ELI LILLY AND COMPANY
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Jarrow Formulas, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Source Naturals, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Neurohacker Collective
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Herbalife Nutrition Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kyowa Hakko Bio Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hubei Huitian Pharmaceutical Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hunan Dongting Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 Jiangsu Nanshan Pharmaceutical Co., Ltd.
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Citicoline Sales Market, By Application
    • 6.1.1 Memory Enhancement
    • 6.1.2 Alzheimer’s Disease Treatment
    • 6.1.3 Stroke Recovery
    • 6.1.4 Parkinson’s Disease Treatment
    • 6.1.5 ADHD Treatment
  • 6.2 Citicoline Sales Market, By Product Type
    • 6.2.1 Tablets
    • 6.2.2 Capsules
    • 6.2.3 Liquid
  • 6.3 Citicoline Sales Market, By Ingredient Type
    • 6.3.1 Cytidine
    • 6.3.2 Choline
  • 6.4 Citicoline Sales Market, By Distribution Channel
    • 6.4.1 Hospital Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Citicoline Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Citicoline Sales market is categorized based on

By Product Type

• Tablets
• Capsules
• Liquid

By Application

• Memory Enhancement
• Alzheimer’s Disease Treatment
• Stroke Recovery
• Parkinson’s Disease Treatment
• ADHD Treatment

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Ingredient Type

• Cytidine
• Choline

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Kyowa Hakko Bio Co., Ltd.
• Hunan Dongting Pharmaceutical Co., Ltd.
• PharmaCom Bio Inc.
• Jiangsu Nanshan Pharmaceutical Co., Ltd.
• Neurohacker Collective
• Ginkgo BioWorks
• Hubei Huitian Pharmaceutical Co., Ltd.
• Thermo Fisher Scientific Inc.
• Herbalife Nutrition Ltd.
• NOW Foods
• NutraBlast
• Life Extension
• ELI LILLY AND COMPANY
• Jarrow Formulas, Inc.
• BrainMD Health
• Source Naturals, Inc.